Understand the source comparison
Travel with Glow Stack Airplane TSA: Storage & Screening Comparison
Lyophilised (unreconstituted) powder −20°C Up to 25°C for 48 hours Declare at checkpoint; present vials separately; documentation recommended Insulated pouch or passive cooler with gel packs 24–48 hours before degradation risk Best option for air travel; wides
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Lyophilised (unreconstituted) powder
- −20°C
- Up to 25°C for 48 hours
- Declare at checkpoint; present vials separately; documentation recommended
- Insulated pouch or passive cooler with gel packs
- 24–48 hours before degradation risk
- Best option for air travel; widest stability margin and simplest logistics
- Reconstituted (mixed with bacteriostatic water)
- 2–8°C (refrigeration)
- Zero. Exceeding 8°C causes denaturation
- Declare at checkpoint; present vials with cooling pack; documentation required
- Medical-grade insulin cooler or portable electric refrigerator
- Under 2 hours before integrity risk
- High-risk transport; requires active temperature control and backup cooling; avoid unless absolutely necessary
- Pre-loaded syringes (ready to inject)
- Declare syringes and vials; present with sharps container; expect secondary screening
- Portable electric refrigerator with continuous monitoring
- Under 1 hour before integrity risk
- Not recommended for air travel; highest failure rate and logistical complexity
- The table makes clear what experienced researchers already know: if you must travel with Glow Stack through airplane TSA security, transport the peptides in lyophilised form and reconstitute them at your destination. The stability margin is exponentially wider, the cooling requirements are simpler, and the risk of catastrophic temperature excursions drops to near zero.